Showing results (531-540 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|October 21, 2024
Trends in the prescription of immune checkpoint inhibitors for non-small cell lung cancer in the Netherlands from 2016 to 2020, a national cancer registry analysisErick Suazo-Zepeda, Willemijn J Maas, Petra C Vinke, et al.
Translational Lung Cancer Research|October 21, 2024
Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case reportGaspard Naulleau, Isabelle Monnet, Gaëlle Rousseau-Bussac, et al.
Translational Lung Cancer Research|October 21, 2024
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesotheliomaLinda Ye, Heeju Ryu, David Granadier, et al.
Translational Lung Cancer Research|October 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case reportEdyta M Urbanska, Morten Grauslund, Siv M S Berger, et al.
Translational Lung Cancer Research|October 21, 2024
Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground-glass opacity: a propensity score-matched analysisHideaki Furuse, Yuji Matsumoto, Toshiyuki Nakai, et al.
Translational Lung Cancer Research|October 21, 2024
Establishing a predictive model for tumor mutation burden status based on 18F-FDG PET/CT and clinical features of non-small cell lung cancer patientsZheng Chen, Xueping Chen, Linjun Ju, et al.
Translational Lung Cancer Research|May 22, 2026
Prolonged complete metabolic response to chemotherapy combined with amivantamab with high grade cutaneous toxicity after osimertinib resistance in an uncommon T751_I759delinsAsp EGFR-mutant lung adenocarcinoma: a case reportJean-Baptiste Barbe-Richaud, Erwan Pencreach, Roland Schott, et al.
Translational Lung Cancer Research|May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in KRASG12C -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumorsHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research|May 22, 2026
The IASLC grading system as a predictor for EGFR-TKI therapy in patients with EGFR-mutant lung adenocarcinomaChaoqiang Deng, Molin Zhang, Fangqiu Fu, et al.
Translational Lung Cancer Research|May 22, 2026
Gender disparities in the overall survival of patients with minimally invasive squamous cell carcinoma of the lung: a retrospective analysis of the Surveillance, Epidemiology, and End Results Program databaseYucheng Ma, Jiayue Ye, Jiacong Liu, et al.
Pageof 240